Inhibrx logo
Inhibrx INBX
$ 14.09 0.79%

Annual report 2023
added 02-28-2024

report update icon

Inhibrx Balance Sheet 2011-2024 | INBX

Annual Balance Sheet Inhibrx

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-275 M -269 M -125 M -95.9 M 30.2 M 7.39 M 1.19 M - - - - - -

Long Term Debt

1.11 M 3.17 M 5.03 M 29.2 M 30.4 M 3.56 M 9.49 M - - - - - -

Long Term Debt Current

2.06 M 1.86 M 1.67 M 1.5 M - - - - - - - - -

Total Non Current Liabilities

- - - 36.9 M 99.5 M 51.4 M 30.7 M - - - - - -

Total Current Liabilities

56.3 M 27.6 M 22.5 M 31.4 M - - - - - - - - -

Total Liabilities

264 M 233 M 98.1 M 68.3 M 120 M 67.6 M 39.7 M - - - - - -

Deferred Revenue

- 166 K 2.03 M 3.08 M 7.94 M - - - - - - - -

Retained Earnings

-614 M -372 M -227 M -145 M -69.3 M -17.9 M -28.8 M - - - - - -

Total Assets

308 M 291 M 150 M 144 M 26.5 M 9.98 M 17.2 M - - - - - -

Cash and Cash Equivalents

278 M 274 M 131 M 129 M 11.5 M - - - - - - - -

Book Value

43.5 M 58.1 M 52.4 M 75.5 M -93.6 M -57.6 M -22.4 M - - - - - -

Total Shareholders Equity

43.5 M 58.1 M 52.4 M 75.5 M -93.6 M - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Inhibrx

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

1.65 M 2.17 M 2.68 M 3.17 M 3.66 M 4.13 M 4.59 M 5.03 M 5.47 M 5.9 M 6.31 M 6.71 M 6.71 M 6.71 M 6.71 M 6.7 M 6.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

243 M 238 M 239 M 233 M 200 M 198 M 134 M 98.1 M 101 M 97.6 M 63.9 M 68.3 M 68.3 M 68.3 M 68.3 M 60.6 M 60.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- 119 K 149 K 166 K 440 K 717 K 1.23 M 2.03 M 2.77 M 3.24 M 4.08 M 3.08 M 3.08 M 3.08 M 3.08 M 7.94 M 7.94 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-520 M -468 M -421 M -372 M -331 M -296 M -258 M -227 M -206 M -185 M -165 M -145 M -145 M -145 M -145 M -69.3 M -69.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

373 M 213 M 254 M 291 M 165 M 193 M 161 M 150 M 129 M 142 M 125 M 144 M 144 M 144 M 144 M 26.5 M 26.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

337 M 192 M 234 M 274 M 146 M 176 M 143 M 131 M 113 M 126 M 108 M 129 M 129 M 129 M 129 M 11.5 M 11.5 M - - 2.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

130 M -24.8 M 15.1 M 58.1 M -35 M -4.92 M 27.4 M 52.4 M 28.2 M 44.3 M 60.6 M 75.5 M 75.5 M 75.5 M 75.5 M -34.1 M -34.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

130 M -24.8 M 15.1 M 58.1 M -35 M -4.92 M 27.4 M 52.4 M 28.2 M 44.3 M 60.6 M 75.5 M 75.5 M 75.5 M 75.5 M -93.6 M -93.6 M -59.2 M -60.6 M -57.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency